Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
May 1, 2018
BrainStorm Cell Therapeutics to Participate in Movement Disorder Panel at the Neurotech Investing and Partnering Conference
NEW YORK and PETACH TIKVAH, Israel, May 1, 2018 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (BCLI), a leading developer of adult stem cell therapies for neurodegenerative ...
May 1, 2018
AzurRx BioPharma Announces Pricing of $10.4 Million Public Offering of Common Stock
BROOKLYN, N.Y., May 01, 2018 (GLOBE NEWSWIRE) -- AzurRx BioPharma (AZRX), (“AzurRx” or the “Company”), today announced the pricing of an underwritten public offering of ...
May 1, 2018
Paratek Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
BOSTON, May 01, 2018 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (PRTK), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon ...
May 1, 2018
Pernix Therapeutics to Report First Quarter 2018 Financial Results on Thursday, May 10
MORRISTOWN, N.J., May 01, 2018 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (PTX), a specialty pharmaceutical company, announced today that the Company will report financial ...
May 1, 2018
Theravance Biopharma to Report First Quarter 2018 Financial Results on May 8, 2018
DUBLIN, May 1, 2018 /PRNewswire/ -- Theravance Biopharma, Inc. (TBPH) ("Theravance Biopharma" or the "Company") today announced that it will release financial results for the ...
May 1, 2018
Prothena to Report First Quarter 2018 Financial Results on May 8
DUBLIN, Ireland, May 01, 2018 (GLOBE NEWSWIRE) -- Prothena Corporation plc (PRTA), a clinical-stage biotechnology company focused on the discovery and development of novel therapies ...
May 1, 2018
TherapeuticsMD to Host First Quarter Financial Results Conference Call and Webcast on May 3
BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (TXMD), an innovative women’s healthcare company, today announced that it will host a conference call and live audio webcast to ...
May 1, 2018
Zogenix Reports Granting of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
EMERYVILLE, Calif., May 01, 2018 (GLOBE NEWSWIRE) -- Zogenix, Inc. (ZGNX), a pharmaceutical company developing therapies for the treatment of rare central nervous system (CNS) ...
April 30, 2018
Kuros Biosciences Reports Full-Year 2017 Results
SCHLIEREN (Zurich), Switzerland, April 30, 2018 (GLOBE NEWSWIRE) -- Kuros Biosciences (SIX:KURN) reported today its Full-Year 2017 Results, and the publication of its annual report. ...
April 30, 2018
Prometic Reports Positive Clinical Data from its Intravenous Immunoglobulin (IVIG) Pivotal Phase 3 Tria
LAVAL, QC , April 30, 2018 /CNW Telbec/ - Prometic Life Sciences Inc. (PLI.TO) (PFSCF) (Prometic)  today announced positive clinical data from its pivotal IVIG phase 3 ...
April 30, 2018
BioDelivery Sciences to Host Conference Call and Webcast Reporting First Quarter 2018 Financial Results on Thursday, May 10
RALEIGH, N.C., April 30, 2018 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (BDSI), a specialty pharmaceutical company with a focus in pain management and addiction ...
April 30, 2018
ProQR Announces Conference Presentations for Axiomer® RNA Editing Technology and QR-313 for DEB
LEIDEN, the Netherlands, April 30, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (PRQR), a company dedicated to changing lives through the creation of transformative RNA ...
April 30, 2018
Conatus Announces Completion of Enrollment in ENCORE-PH Phase 2b Clinical Trial of Emricasan in Patients with NASH Cirrhosis and Severe Portal Hypertension
SAN DIEGO, April 30, 2018 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (CNAT) today announced the completion of enrollment in ENCORE-PH, a Phase 2b clinical trial ...
April 30, 2018
BioLife Solutions Receives $2.6 Million from Exercise of Warrants
BOTHELL, Wash., April 30, 2018 /PRNewswire/ -- BioLife Solutions, Inc. (BLFS), the leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic storage ...
April 30, 2018
Albireo to Present at Deutsche Bank 43rd Annual Health Care Conference
BOSTON, April 30, 2018 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced ...
April 30, 2018
Keryx Biopharmaceuticals Announces Changes to Management and Preliminary First Quarter 2018 Revenue
BOSTON, April 30, 2018 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (KERX), a biopharmaceutical company focused on bringing innovative medicines to people with kidney disease, today ...
April 30, 2018
Pfenex to Report First Quarter 2018 Results and Provide Business Update on Thursday, May 10th
SAN DIEGO, April 30, 2018 /PRNewswire/ -- Pfenex Inc. (NYSE American: PFNX) announced today that its first quarter 2018 financial results will be released on Thursday, ...
April 30, 2018
AzurRx BioPharma Announces Proposed Public Offering of Common Stock
BROOKLYN, N.Y., April 30, 2018 (GLOBE NEWSWIRE) -- AzurRx BioPharma (AZRX), (“AzurRx” or the “Company”), announced today that it intends to offer and sell shares ...
April 27, 2018
Basilea announces appointment of Chief Technology Officer and appointment of Head of Global Quality Management
Basel, Switzerland, April 27, 2018 - Basilea Pharmaceutica Ltd. (SIX:BSLN) reported today that as of May 1, 2018, Dr. Gerrit Hauck is appointed as Chief ...
April 27, 2018
Zealand announces net sales of Soliqua® 100/33 and Lyxumia®/Adlyxin® for the first quarter of 2018
Copenhagen, April 27, 2018 - Zealand Pharma ("Zealand") announces Q1 2018 net sales by Sanofi from Soliqua® 100/33/ Suliqua® of EUR 9.0 million/USD 11.1 million ...
Page 67 of 138